.png)
MILD HYPERBARIC OXYGEN THERAPY (mHBOT)
Mild Hyperbaric Oxygen Therapy (HBOT) takes place in a large, soft wall chamber.
During each 60 minute session the user breathes pure supplemental oxygen while the chamber is pressurized at 30% over regular atmospheric pressure (1.3 ATA). Breathing oxygen at increased pressure enables the body to absorb (and utilize) much higher levels of oxygen enhancing the body’s natural healing process.
The healing power of oxygen is not something new. The use of hyperbaric therapy dates back nearly 350 years. The very first hyperbaric chamber was created in 1662 with the clinical use of hyperbaric oxygen therapy starting in the mid 1800s. During the 1960s, studies began to show a wide variety of beneficial uses for HBOT therapy. Today, there are over 150 internationally approved conditions for which hyperbaric oxygen therapy has been shown to be effective and beneficial.
Health Benefits
Inflammation Reduction
Pain
Relief
Brain Injury
Healing
Cellular
Health
Injury
Rehab
Sleep
Optimization
Neurological
Disorders
Athletic
Recovery
Anti-
Aging
Wound
Healing
Study Links
Parkinsons
Radiation Healing (cancer patients)
“Unlike most conventional treatment that only alleviated symptoms, HBOT can favourably change the natural history of other RT late sequelae[4]. Its clinical benefit emanates from the therapeutic effects of hyperbaric oxygen that include, among others, the promotion of tissue oxygenation, neovascularisation, reepithelialisation, and the reversal of the fibroatrophic process induced by ionising radiation"
Cellular Healing
"HBOT shows remarkable effects on mitochondria, the cell’s energy powerhouse. It improves the mitochondrial redox state, balancing oxidation and reduction, essential for energy production and cellular health. Furthermore, it preserves mitochondrial integrity, protecting vital organs from damage. Another significant aspect is the alleviation of oxidative stress; by reducing this stress, HBOT helps minimize cellular damage."
Cancer Treatment
"However, through studies, physicians determined that cancer cells thrive in oxygen-deprived environments, often resulting in the hypoxemia (inadequate blood oxygen levels) seen in cancer patients. So, contrary to previous beliefs, increased oxygen levels, as delivered through HBOT, hinder cancer growth."
Brain Injury
(pediatric)
"All 12 patients had statistically significant improvements in their Trail Making Test, parts A and B, and U.S. Department of Veterans Affairs' Evaluation of Cognitive Impairment and Subjective Symptoms scores (P < 0.05). Additionally, single-photon emission computed tomography depicted increased cerebral blood flow and oxygen metabolism among studied subjects compared with the baseline values."
(adult)
"significant improvements in postconcussion symptoms and seven other outcome variables [memory, cognition/speed of information processing (a computerized cognitive test battery, ANAM, developed and employed by the U.S. military for TBI), depression, anxiety, PTSD symptoms, sleep, and quality of life] in PPCS subjects treated with HBOT compared to a randomly assigned Control Group during the same period."
"All patients had documented TBI 0.3–33 years (mean 4.6±5.8, median 2.75 years) prior to HBOT. HBOT was associated with significant improvement in all of the cognitive domains, with a mean change in global cognitive scores of 4.6±8.5 (p<0.00001). The most prominent improvements were in memory index and attention, with mean changes of 8.1±16.9 (p<0.00001) and 6.8±16.5 (p<0.0001)"
"The prospective preliminary non-randomized study identified provided evidence to suggest that two weeks of hyperbaric oxygen therapy increased pain thresholds and health-related quality of life and decreased disability in patients with myofascial pain syndrome (MPS) at three months post-treatment."
Long Covid
“HBOT improves dysexecutive functions, psychiatric symptoms (depression, anxiety and somatization), pain interference symptoms and fatigue. Those changes were associated with increased CBF and brain microstructural changes in frontal, parietal and limbic regions associated with cognitive and psychiatric roles.”
Considerations for HBOT use with implanted pain pump:
Implanted devices should be pressure tested to determine their safety and ability to function in a high-pressure environment. Most have been pressure tested to withstand 100 FSW (4 ATA). However, it is always advisable to check with the manufacturer. While there have not been any case reports of an internal cardiac defibrillator triggering a fire in a patient in the hyperbaric chamber, it is possible to turn them off during treatment (if there is an acceptable risk of dysrhythmia).
Patients with epidural pain pumps are at risk of device malfunction or deformation under pressure. Contact the manufacturer to verify the pressure limitations of the specific device.
Our hyperbaric goes to 1.3 ATA. So, pressure rating on your pump needs to be able to withstand 50 FSW.